Markers of apoptosis and proliferation related gene products as predictors of treatment outcome in childhood acute lymphoblastic leukemia

References

• Chaudhuri K, Sinha A, Had GC, Karmakar R, Banerjee A. Childhood alignancies at BS medical college: A ten year study. Indian J Pathol Microbiol 2003;46:194–196.
   Google Scholar
• Hafez M, El-Tahan H, El-Morsy Z, Al-Tonbary Y, El-Zeiny M, Sirag S, El-Serafi M. Genetic- environmental interaction in acute lymphatic leukemia. In: Muller HJW, editor. Familial cancer. New York: Karger; 1985. p 161–166.
   Google Scholar
• Sato T, Machida T, Takahashi S, Iyama S, Sato Y, Kuribayashi K, Takada K, Oku T, Kawano Y, Okamoto T, Takimoto R, Matsunaga T, Takayama T, Takahashi M, Kato J, Niitsu Y. Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells. J Immunol 2004;173:285–296.
   PubMed Web of Science ®Google Scholar
• Bohana-Kashtan O, Civin CI. Fas ligand as a tool for immunosuppression and generation of immune tolerance. Stem Cells 2004;22:908–924.
   Google Scholar
• Rantanen S, Mormi O, Joensuu H, Franssila K, Knuutila S. Causes and consequences of BCL2 overexpression in diffuse large B-cell lymphoma. Leuk Lymphoma 2001;42: 1089–1098.
   PubMed Web of Science ®Google Scholar
• Wang D, Freeman GJ, Levine H, Ritz J, Robertson MJ. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies. Br J Haematol 1997;97: 409–417.
   PubMed Web of Science ®Google Scholar
• Zhou M, Glyafhw. Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bc1-2 expression. Leukemia 199812:1756-1763.
   PubMed Web of Science ®Google Scholar
• Maluynikola V, Bradstock KR Adhesion of precursor-B acute lymphoblastic leukaemia cells to bone marrow stromal proteins. Leukemia 1993;7:86–92.
   PubMed Web of Science ®Google Scholar
• Tsuji T, Waga I, Tezuka K, Kamada M, Yatsunami K, Kodama H. Integrin beta2 (CD18)-mediated cell proliferation of HEL cells on a hematopoietic-supportive bone marrow stromal cell line, HESS-5 cells. Blood 1998;91:1263–1271.
   PubMed Web of Science ®Google Scholar
• Gruss HJ, Ulrich D, Dower SK, Herrmann F, Brach MA. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor. Blood 1996;87: 2443–2449.
   PubMed Web of Science ®Google Scholar
• Frelin C, Imbert V, Griessinger E, Peyron AC, Rochet N, Philip P, Dageville C, Sirvent A, Hummelsberger M, Berard E, Dreano M, Sirvent N, Peyron JF. Targeting NF-kappaB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells. Blood 2005;105: 804–811.
   PubMed Web of Science ®Google Scholar
• Riehm H, Gadner H, Hemze G, et al. Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematol Blood Transfus 1990;33:439–450.
   PubMedGoogle Scholar
• Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifu-gation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968;97: 77–89.
   PubMedGoogle Scholar
• Padayatty SJ, Marcelli M, Shao TrC, Cunningham GR. Lovastatin-induced apoptosis in prostate stromal cells. J Clin Endocrinol Metab 1997;82:1434–1439.
   PubMed Web of Science ®Google Scholar
• Fluckiger AC, Durand I, Banchereau J. Interleukin 10 induced apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 1994;179: 91–99.
   PubMed Web of Science ®Google Scholar
• Hughes FM, Jr., Gorospe WC. Biochemical identification of apoptosis (programmed cell death) in granulose cells: Evidence for a potential mechanism underlying follicular atresia. Endocrinology 1991;129:2415–2422.
   Google Scholar
• Friedmann AM, Weinstein HJ. The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia. Oncologist 2000;5:321–328.
   PubMedGoogle Scholar
• Liu T, Raetz E, Moos PJ, Perkins SL, Bruggers CS, Smith F, Carroll WL. Diversity of the apoptotic response to chemother-apy in childhood leukemia. Leukemia 2002;16:223–232.
   Google Scholar
• Maruyama W, Irie S, Sato TA. Morphological changes in the nucleus and actin cytoskeleton in the process of Fas-induced apoptosis in Jurkat T cells. Histochem J 2000; 32:495–503.
   Google Scholar
• Schuler D, Szende B. Apoptosis and acute lymphocytic leukemia in children. Ann NY Acad Sci 1997;824:28–37.
   PubMed Web of Science ®Google Scholar
• Tsangaris GT, Moschovi M, Mikraki V, Vrachnou E, Tzortzatou-Stathopoulou F. Study of apoptosis in peripheral blood of patients with acute lymphoblastic leukemia during induction therapy. Anticancer Res 1996;16:3133–3140.
   Google Scholar
• Volm M, Zintl F, Sauerbrey A, Koomagi R. Proliferation and apoptosis in newly diagnosed and relapsed childhood acute lymphoblastic leukemia. Anticancer Res 1999;19:4327–4331.
   PubMed Web of Science ®Google Scholar
• Baryshnikov AY, Polosukhina ER, Tupitsin NN, Gavrikova NV, Andreeva LY, Zabotina TN, Mayakova SA, Kurmashov VI, Syrkin AB, Kadagidze ZG, Blochin DY, Shishkin Y. CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients. Adv Exp Med Biol 1999;457:251–258.
   PubMed Web of Science ®Google Scholar
• Tsuruda K, Yamada Y, Hirakata Y, Sugahara K, Maeda T, Atogami S, Tomonaga M, Kamihira S. Qualitative and quantitative characterization of Fas (APO-1/CD95) on leukemic cells derived from patients with B-cell neoplasms. Leuk Res 1999;23:159–166.
   PubMed Web of Science ®Google Scholar
• Zhou M, Gu L, Yeager AM, Findley HW Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression. Leukemia 199812:1756-1763.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhou J, Yue B, Xiang Z, Song X, Li C, Wang B. Bc1-2 gene and its family genes Bax, Bc1-X1 as well as Fas/Apo-1 and their clinical significance in acute leukemia. Chin Med J (Engl) 1998;111: 682–685.
   PubMed Web of Science ®Google Scholar
• Srinivas G, Kusumakumary P, Nair MK, Panicker KR, Pillai MR. Mutant p53 protein, Bc1-2/Bax ratios and apoptosis in paediatric acute lymphoblastic leukaemia. J Cancer Res Clin Oncol 2000;126: 62–67.
   PubMed Web of Science ®Google Scholar
• Campos L, Sabido O, Viallet A, Vasselon C, Guyotat D. Expression of apoptosis-controlling proteins in acute leukemia cells. Leuk Lymphoma 1999;33:499–509.
   PubMed Web of Science ®Google Scholar
• Piccioli P, Porcile C, Stanzione S, Bisaglia M, Bajetto A, Bonavia R, Florio T, Schettini G. Inhibition of nuclear factor-kappaB activation induces apoptosis in cerebellar granule cells. J Neurosci Res 2001;66:1064–1073.
   PubMed Web of Science ®Google Scholar
• Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J Virol 2004;78: 4108–4119.
   PubMed Web of Science ®Google Scholar
• Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C. Transcription factor NF-kappaB is constitu-tively activated in acute lymphoblastic leukemia cells. Leukemia 2000;14:399–402.
   Google Scholar
• Mengarelli A, Zarcone D, Caruso R, Tenca C, Rana I, Pinto RM, Grossi CE, De RG. Adhesion molecule expression, clinical features and therapy outcome in child-hood acute lymphoblastic leukemia. Leuk Lymphoma 2001; 40:625–630.
   PubMed Web of Science ®Google Scholar
• Horst E, Radaszkiewicz T, Hooftman-den Otter A, Pieters R, van Dongen JJ, Meijer CJ, Plas ST. Expression of the leucocyte integrin LEA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade. Leukemia 1991;5(10):848–853.
   PubMed Web of Science ®Google Scholar
• Geijtenbeek TB, van KY, van Vliet SJ, Renes MH, Raymakers RA, Figdor CG. High frequency of adhesion defects in B-lineage acute lymphoblastic leukemia. Blood 1999;94:754–764.
   PubMed Web of Science ®Google Scholar